| Ident. | Authors (with country if any) | Title |
|---|
| 000047 (1989) |
H. Taquet [France] ; F. Javoy-Agid [France] ; A. Mauborgne [France] ; J. J. Benohel [France] ; Y. Agid [France] ; F. Cesselin [France] ; M. Hamon [France] | Neuropeptides in the basal ganglia of patients with Parkinson's or Steele‐Richardson's disease |
| 000068 (1983) |
F. Javoy-Agid ; D. Grouselle ; A. Tixier-Vidal ; Y. Agid | Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease |
| 000185 (1983) |
M. Garbarg [France] ; F. Javoy-Agid [France] ; J. C. Schwartz [France] ; Y. Agid [France] | BRAIN HISTIDINE DECARBOXYLASE ACTIVITY IN PARKINSON'S DISEASE |
| 000190 (1990) |
I. Ceballos [France] ; M. Lafon [France] ; F. Javoy-Agid [France] ; E. Hirsch [France] ; A. Nicole [Royaume-Uni] ; P. M. Sinet [Royaume-Uni] ; Y. Agid [Royaume-Uni] | Superoxide dismutase and Parkinson's disease |
| 000214 (1984) |
Howardi Hurtig [États-Unis] ; C. Miller Fisher [États-Unis] ; E. Ringwald [Suisse] ; M. Ruberg [France] ; F. Javoy-Agid [France] ; Y. Agid [France] | WHAT CAUSES PARKINSON'S DISEASE? |
| 000309 (1985) |
H. Taquet [France] ; F. Javoy-Agid [France] ; P. Giraud [France] ; J. C. Legrand [France] ; Y. Agid [France] ; F. Cesselin [France] | Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain |
| 000319 (1983) |
A. Mauborgne [France] ; F. Javoy-Agid [France] ; J. C. Legrand [France] ; Y. Agid [France] ; F. Cesselin [France] | Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains |
| 000415 (1985) |
L. Pique [France] ; S. Jegou [France] ; X. Bertagna [France] ; F. Javoy-Agid [France] ; D. Seurin [France] ; M. F. Proeschel [France] ; F. Girard [France] ; Y. Agid [France] ; H. Vaudry [France] ; J. P. Luton [France] | Pro-opiomelanocortin peptides in the human hypothalamus: Comparative study between normal subjects and parkinson patients |
| 000444 (1982) |
J. M. Studler [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; J. C. Legrand [France] ; Y. Agid [France] | CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients |
| 000461 (1993) |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Y. Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 000505 (1985) |
J. M. Allen [Royaume-Uni] ; A. J. Cross [Royaume-Uni] ; T. J. Crow [Royaume-Uni] ; F. Javoy-Agid [France] ; Y. Agid [France] ; S. R. Bloom [Royaume-Uni] | Dissociation of neuropeptide Y and somatostatin in Parkinson's disease |
| 000515 (1983) |
H. Taquet [France] ; F. Javoy-Agid [France] ; M. Hamon [France] ; J. C. Legrand [France] ; Y. Agid [France] ; F. Cesselin [France] | Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain |
| 000527 (1985) |
B. Conte-Devolx [France] ; M. Grino [France] ; A. Nieoullon [France] ; F. Javoy-Agid [France] ; E. Castanas [France] ; V. Guillaume [France] ; M. C. Tonon [France] ; H. Vaudry [France] ; C. Oliver [France] | Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus |
| 000567 (1988) |
H. Taquet [France] ; M. Nomoto [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; F. Javoy-Agid [Royaume-Uni] ; A. Mauborgne [France] ; J. J. Benoliel [France] ; C. D. Marsden [Royaume-Uni] ; J. C. Legrand [France] ; Y. Agid [France] ; M. Hamon [France] ; F. Cesselin [France] | Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment |
| 000715 (1996) |
J. L. Pezzoli [Italie] ; O. Strada [Italie] ; V. Silani [Italie] ; A. Zecchinelli [Italie] ; L. Perbellini [France] ; F. Javoy-Agid [Italie] ; P. Ghidoni [Italie] ; E. D. F. Motti [Italie] ; T. Masini [Italie] ; G. Scarlato [Italie] ; Y. Agid [Italie] ; E. C. Hirsch [Italie] | Clinical and pathological features in hydrocarbon‐induced Parkinsonism |
| 000725 (1988) |
J. Epelbaum [France] ; F. Javoy-Agid [France] ; A. Enjalbert [France] ; S. Krantic [France] ; C. Kordon [France] ; Y. Agid [France] | Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy |
| 000756 (1988) |
Glenn M. Maloteaux [Belgique] ; E. C. Laterre [Belgique] ; P. M. Laduron [France] ; F. Javoy-Agid [France] ; Y. Agid [France] | Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy |
| 000854 (1987) |
P. Delay-Goyet [France] ; J.-M. Zajac [France] ; F. Javoy-Agid [France] ; Y. Agid [France] ; B. P. Roques [France] | Regional distribution of μ, δ and κ opioid receptors in human brains from controls and parkinsonian subjects |
| 000900 (1993) |
A. Kastner [France] ; E. C. Hirsch [France] ; Y. Agid [France] ; F. Javoy-Agid [France] | Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease |
| 000E92 (1990) |
E. C. Hirsch [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; J. Hauw [France] ; Y. Agid [France] | Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease? |
| 001201 (1990) |
F. Javoy-Agid [France] ; E. C. Hirsch [France] ; S. Dumas [France] ; C. Duyckaerts [France] ; J. Mallet [France] ; Y. Agid [France] | Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in parkinson's disease: An in situ hybridization study |
